Critical Contrast: MusclePharm (OTCMKTS:MSLP) and Vectura Group (OTCMKTS:VEGPF)

Profitability

This table compares MusclePharm and Vectura Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
MusclePharm	-38.51%	N/A	-169.56%
Vectura Group	N/A	N/A	N/A

Valuation and Earnings

This table compares MusclePharm and Vectura Group”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MusclePharm	$50.04 million	0.00	-$12.87 million	($0.58)	N/A
Vectura Group	$244.76 million	4.37	$157.16 million	$0.26	6.81

Vectura Group has higher revenue and earnings than MusclePharm. MusclePharm is trading at a lower price-to-earnings ratio than Vectura Group, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

MusclePharm has a beta of -0.07, meaning that its share price is 107% less volatile than the S&P 500. Comparatively, Vectura Group has a beta of 0.37, meaning that its share price is 63% less volatile than the S&P 500.

Institutional & Insider Ownership

15.5% of MusclePharm shares are held by institutional investors. 60.7% of MusclePharm shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Vectura Group beats MusclePharm on 7 of the 9 factors compared between the two stocks.

About MusclePharm

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.

About Vectura Group

Vectura Group Plc engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom.